Endothelin-1--marker or mediator of vascular disease?
Stewart, D.J.
Canadian Journal of Cardiology 6(8): Viii
1990
ISSN/ISBN: 0828-282X PMID: 2268791 Document Number: 356903
Document emailed within 1 workday
Related Documents
Morelli, S.; Ferri, C. 1996: Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Journal of Rheumatology 23(4): 789-791Juan, C.C.; Fang, V.S.; Hsu, Y.P.; Huang, Y.J.; Hsia, D.B.; Yu, P.C.; Kwok, C.F.; Ho, L.T. 1998: Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model Journal of Hypertension 16(12 Pt 1): 1775-1782
Hladík, M.; Olosová, A.; Neiser, J.; Zaoral, T. 2005: Procalcitonin--a marker and mediator of inflammation Acta Chirurgiae Plasticae 47(2): 51-54
Cleland, J.G.; Clark, A.L. 1998: Leptin and cardiac cachexia: marker or mediator? European Heart Journal 19(10): 1421-1422
Duclos, B. 2001: Ambiguous relationships between vascular thrombosis and Crohn's disease: cause or marker? Gastroenterologie Clinique et Biologique 25(8-9): 743-744
Jensen, T. 1991: Albuminuria--a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus Danish Medical Bulletin 38(2): 134-144
Siminiak, T.; Wysocki, H. 1994: Endothelin. II. The role of endothelin in the pathogenesis of disease Przeglad Lekarski 51(12): 527-530
Berthiaume, N.; Yanagisawa, M.; D'Orléans-Juste, P. 2000: Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice Journal of Cardiovascular Pharmacology 36(5 Suppl 1: S72-S74
Bray, M.A. 1982: Leukotriene B4: an inflammatory mediator with vascular actions in vivo Agents and Actions. Supplements 11: 51-61
Levada, O.A.; Traïlin, A.V. 2012: Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness Likars'ka Sprava 2012(3-4): 53-59
Tamura, D.Y.; Minkes, R.K.; Bellan, J.A.; McMahon, T.J.; McNamara, D.B.; Kadowitz, P.J. 1992: Analysis of responses to big endothelin in the hindquarters vascular bed of the cat Canadian Journal of Cardiology 8(9): 954-960
Hughes, A.D.; Thom, S.A.; Woodall, N.; Schachter, M.; Hair, W.M.; Martin, G.N.; Sever, P.S. 1989: Human vascular responses to endothelin-1: observations in vivo and in vitro Journal of Cardiovascular Pharmacology 13(Suppl 5): S225-S228
King-VanVlack, C.E.; Mewburn, J.D.; Chapler, C.K. 1999: Receptor-mediated vascular and metabolic actions of endothelin-1 in canine small intestine American Journal of Physiology 276(5): G1131-G1136
Malek, A.M.; Lee, I.W.; Alper, S.L.; Izumo, S. 1997: Regulation of endothelin-1 gene expression by cell shape and the microfilament network in vascular endothelium American Journal of Physiology 273(5): C1764-C1774
Tjen-A-Looi, S.; Ekman, R.; Osborn, J.; Keith, I. 1996: Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study American Journal of Physiology 271(6 Pt 2): H2246-H2253
Minamino, T.; Kurihara, H.; Takahashi, M.; Shimada, K.; Maemura, K.; Oda, H.; Ishikawa, T.; Uchiyama, T.; Tanzawa, K.; Yazaki, Y. 1997: Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis Circulation 95(1): 221-230
Wang, H-yu. 2010: Vascular medicine:vascular health evaluation and vascular disease prevention and medication Zhonghua Yi Xue Za Zhi 90(30): 2092-2093
Bertelli, A.; Giovannini, L.; Galmozzi, G.; Bertelli, A.A. 1993: Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin Drugs under Experimental and Clinical Research 19(1): 7-11
Resink, T.J.; Scott-Burden, T.; Boulanger, C.; Weber, E.; Bühler, F.R. 1990: Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance Molecular Pharmacology 38(2): 244-252
Moreau, P.; Takase, H.; Küng, C.F.; Shaw, S.; Lüscher, T.F. 1997: Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension Hypertension 29(3): 763-769